摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-butyl-3-hydroxymethyl-2-pyridone

中文名称
——
中文别名
——
英文名称
1-butyl-3-hydroxymethyl-2-pyridone
英文别名
1-butyl-3-(hydroxymethyl)pyridin-2-one
1-butyl-3-hydroxymethyl-2-pyridone化学式
CAS
——
化学式
C10H15NO2
mdl
——
分子量
181.235
InChiKey
YUCPMJNNPQAHTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Antipruritics
    申请人:Yasui Kiyoshi
    公开号:US20050101590A1
    公开(公告)日:2005-05-12
    It is intended to provide antipruritics (drugs to control itching, antiitch agents and drugs to stop itching). It is found out that a compound having an agonistic activity to the cannabinoid receptor shows an antipruritics effect.
    这意味着它旨在提供止痒药(用于控制瘙痒的药物,抗瘙痒剂和止痒药)。研究发现,具有激动性作用的大麻素受体的化合物具有止痒效果。
  • Pyridone derivatives having affinity for cannabinoid 2-type receptor
    申请人:——
    公开号:US20040082619A1
    公开(公告)日:2004-04-29
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): 1 wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    发现具有与cannabinoid 2型受体结合活性的化合物,其代表式为(I):1其中R1是由式表示的基团:—Y1—Y2—Y3—Ra其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选取代芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选取代烷基或类似物;或R3和R4与相邻原子结合形成环状基团或类似物。
  • Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
    申请人:Tada Yukio
    公开号:US20060052411A1
    公开(公告)日:2006-03-09
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    被发现的化合物具有与cannabinoid type 2 受体结合活性,其化学式为(I),其中R1是由公式表示的基团:—Y1—Y2—Y3—Ra,其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选择取代的芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选择取代的烷基或类似物;或R3和R4与相邻原子一起形成环状基团或类似物。
  • Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
    申请人:TADA Yukio
    公开号:US20100081686A1
    公开(公告)日:2010-04-01
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    发现化合物具有与cannabinoid type 2受体结合活性,该化合物的公式为(I):其中R1是由公式表示的基团:—Y1—Y2—Y3—Ra,其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选择的取代芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选择的取代烷基或类似物;或R3和R4与相邻原子结合形成环状基团或类似物。
  • PYRIDONE DERIVATIVE HAVING AFFINITY FOR CANNABINOID 2-TYPE RECEPTOR
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1357111A1
    公开(公告)日:2003-10-29
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R' is a group represented by the formula: -Y1-Y2-Y3Ra wherein Y1 is single bond or the like; Y2 is -C(=O)-NH- or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    研究发现,对大麻素 2 型受体具有结合活性的化合物由式(I)表示: 其中 R' 是由式表示的基团:-其中 Y1 是单键或类似物;Y2 是-C(=O)-NH- 或类似物;Y3 是任选取代的芳基或类似物;R2 是氢或类似物;R3 是烷基或类似物;R4 是烷基或类似物;R5 是任选取代的烷基或类似物;或 R3 和 R4 与相邻原子一起形成环状基团或类似物。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-